Ayala Pharmaceuticals Inc (ADXS)

[Gantor50]

I agree mostly.

Although I still wonder if the BOD still believes that ADXS is worth the $6+B floated by DOC a number of times? And now they have collectively dug in their heels against any deals suggesting a significantly lesser valuation?

Unfortunately my personal view hasn't changed in the last 12 months. All of ADXS is worth between $500M to $750M in a sale, maybe $1B with future data readouts and European approval for AXAL.

While a AMGN or Merck might be able to capitalize ADXS portfolio and convert that to eventual realized annual sales of $5B to $10B, ADXS does not have the financial or human resources to ever come close to that.

It's like a poor man owning a piece of prime real estate. The poor man will never be able to get the funds to fully realize it's full potential. They can only hope to sell it to the highest bidder and receive the value of the undeveloped real estate only.